OTC · Health care

Procyon Corp (PCYN)

Procyon Corp reported revenue of $5M in fiscal 2024, up 6.4% from a year earlier. It posted a net loss of $341.1K. In fiscal 2024 capital spending exceeded operating cash flow by $125.2K. At June 30, 2024 it held $326.1K in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on October 25, 2024.

Watch PCYN in 60 seconds

Price

$0.27

+3.85% on the day · September 25, 2026

52-week range $0.11 to $0.28

Market cap

$2.2M

Revenue (FY2024)

$5M

+6.4% year on year

Net margin

-6.8%

What Procyon Corp does

Procyon Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker PCYN.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2024	$5M	-$231.7K	-$341.1K	-$0.04	-$125.2K
2023	$4.7M	-$97.4K	-$50.2K	-$0.01	-$34.7K
2022	$4.8M	-$237.2K	-$209.8K	-$0.03	-$466.1K
2021	$4.7M	$226.7K	$694.3K	$0.08	$214.3K
2020	$4.3M	$153K	$111.7K	$0.01	$175.7K
2019	$4.2M	$97.1K	$27.2K	$0.00	$22.1K

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Procyon Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

November 8, 2024
Deregistration 15-12G
November 8, 2024
Other event 8-K
October 25, 2024
Annual report 10-K · period to June 30, 2024Revenue rose 6.4% to $5M versus the prior year; diluted EPS -$0.04 versus -$0.01.
October 22, 2024
Other event 8-K
September 30, 2024
Late annual report notice NT 10-K
May 24, 2024
Quarterly report 10-Q · period to March 31, 2024Revenue rose 6.6% to $1.2M versus the same quarter last year; diluted EPS -$0.01 versus $0.00.
May 20, 2024
Late quarterly report notice NT 10-Q
February 22, 2024
Quarterly report 10-Q · period to December 31, 2023Revenue rose 1.4% to $1.2M versus the same quarter last year; diluted EPS -$0.03 versus $0.00.
February 13, 2024
Late quarterly report notice NT 10-Q
January 4, 2024
Passive stake changed SC 13G/A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 23, 2024. Insider transactions on SEC

All filings on SEC EDGAR

Questions about PCYN

What does Procyon Corp do?

Procyon Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker PCYN.

Is Procyon Corp profitable?

No. In fiscal 2024 it reported a net loss of $341.1K on revenue of $5M.

How much revenue does Procyon Corp make?

In fiscal 2024 Procyon Corp reported revenue of $5M. That is 6.4% more than a year earlier.

When did Procyon Corp last report?

Its most recent periodic report is the annual report (10-K) filed on October 25, 2024. It covers the period to June 30, 2024. Its newest filing of any kind is the deregistration from November 8, 2024.

Similar companies

TAK

Takeda Pharmaceutical Co Ltd

Compare PCYN with

Compare PCYN with any company

Follow PCYN

Get an email when Procyon Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow PCYN: get an email when it files

Where the numbers come from

Financial figures are the values Procyon Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.